Novartis has been granted a patent for a pharmaceutical container featuring a hollow body with a window and a Near Field Communication (NFC) antenna. The method outlined includes authenticating the container by writing and communicating information via the NFC antenna, enhancing product verification. GlobalData’s report on Novartis gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Novartis, Cancer treatment biomarkers was a key innovation area identified from patents. Novartis's grant share as of June 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
Pharmaceutical container with nfc antenna for authentication
The patent US12042467B2 outlines a method for authenticating a container, particularly in the context of pharmaceutical products. The method involves a container with a hollow chamber and a sidewall that features a Near Field Communication (NFC) antenna. This antenna consists of one or more windings that define an interior space, which includes both longitudinally and circumferentially extending portions. The longitudinally extending portion covers less than 180 degrees of the sidewall's circumference, allowing for the writing and communication of essential product information, such as type, production date, and storage life, to an NFC reader. The container can be cylindrical and may have a partially transparent sidewall to enable visualization of its contents.
Additionally, the method allows for the writing of a second set of information into the NFC antenna after the initial communication, which can include patient-specific details and admission dates. The process is designed to facilitate the transportation of pharmaceutical containers to pharmacies, where the product information can be easily accessed and verified. The transparent portion of the container enhances usability by allowing users to see the fill level of the pharmaceutical product. Overall, the claims emphasize the integration of NFC technology in pharmaceutical packaging to improve authentication and information accessibility.
To know more about GlobalData’s detailed insights on Novartis, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
